Akero Therapeutics, Inc. (AKRO)
NASDAQ: AKRO · Real-Time Price · USD
47.53
+0.80 (1.71%)
Sep 2, 2025, 10:03 AM - Market open
Akero Therapeutics Market Cap
Akero Therapeutics has a market cap or net worth of $3.80 billion as of September 2, 2025. Its market cap has increased by 130.46% in one year.
Market Cap
3.80B
Enterprise Value
2.69B
1-Year Change
130.46%
Ranking
Category
Stock Price
$47.53
Market Cap Chart
Since June 20, 2019, Akero Therapeutics's market cap has increased from $495.47M to $3.80B, an increase of 667.33%. That is a compound annual growth rate of 38.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 3.74B | 92.49% |
| Dec 31, 2024 | 1.94B | 49.28% |
| Dec 29, 2023 | 1.30B | -49.24% |
| Dec 30, 2022 | 2.56B | 247.29% |
| Dec 31, 2021 | 737.89M | -17.63% |
| Dec 31, 2020 | 895.82M | 41.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 20, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.66B |
| Johnson & Johnson | 426.69B |
| AbbVie | 371.68B |
| UnitedHealth Group | 280.64B |
| Novo Nordisk | 249.87B |
| AstraZeneca | 246.96B |
| Novartis AG | 244.78B |
| Abbott Laboratories | 230.89B |